More articles from Clinical

You have access
PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
Winfried Brenner, Joachim Strobel and Vikas Prasad

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737
Open Access
Head-to-Head Comparison of ⁶⁸Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
You have access
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791
You have access
Toward a Universal Readout for ¹⁸F-Labeled Amyloid Tracers: The CAPTAINs Study
Gérard N. Bischof, Peter Bartenstein, Henryk Barthel, Bart van Berckel, Vincent Doré, Thilo van Eimeren, Norman Foster, Jochen Hammes, Adriaan A. Lammertsma, Satoshi Minoshima, Chris Rowe, Osama Sabri, John Seibyl, Koen Van Laere, Rik Vandenberghe, Victor Villemagne, Igor Yakushev and Alexander Drzezga

Journal of Nuclear Medicine July 1, 2021, 62 (7) 999-1005; DOI: https://doi.org/10.2967/jnumed.120.250290
You have access
Early Treatment Response Assessment Using ¹⁸F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine July 1, 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
You have access
Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
Toshihiko Goto, Shohei Kikuchi, Kento Mori, Takafumi Nakayama, Hidekatsu Fukuta, Yoshihiro Seo, Hitomi Narita, Akihiko Iida and Nobuyuki Ohte

Journal of Nuclear Medicine July 1, 2021, 62 (7) 996-998; DOI: https://doi.org/10.2967/jnumed.120.253419
You have access
First Experiences with ¹⁷⁷Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients
Vikas Prasad, Friedemann Zengerling, Jochen P. Steinacker, Christian Bolenz, Meinrad Beer, Thomas Wiegel, Matthias Eiber, Neil Fleshner and Ambros J. Beer

Journal of Nuclear Medicine July 1, 2021, 62 (7) 975-978; DOI: https://doi.org/10.2967/jnumed.120.249029
You have access
¹¹C-Sorafenib and ¹⁵O-H₂O PET for Early Evaluation of Sorafenib Therapy
Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt

Journal of Nuclear Medicine July 1, 2021, 62 (7) 934-940; DOI: https://doi.org/10.2967/jnumed.120.251611
You have access
Positive Predictive Value and Correct Detection Rate of ¹⁸F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, Isabel Rauscher, Thomas Langbein, Stephan G. Nekolla, Kilian Schiller, Matthias M. Heck, Tobias Maurer, Alexander Wurzer, Hans-Juergen Wester, Calogero D’Alessandria, Wolfgang Weber and Matthias Eiber

Journal of Nuclear Medicine July 1, 2021, 62 (7) 968-974; DOI: https://doi.org/10.2967/jnumed.120.255661
You have access
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1006-1011; DOI: https://doi.org/10.2967/jnumed.120.254656

Main menu

User menu

Search

More articles from Clinical

Pages